Science Explorer Back to mapMap
Discussion
Researcher · Daiichi-Sankyo (Japan) · Japan

Kenji Hirotani

Kenji Hirotani publishes mostly in Oncology, Organic Chemistry and Molecular Biology, on topics such as HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research and Lung Cancer Treatments and Mutations.

OpenAlex
World rank
#993,040
of 7,710,434 ranked researchers
Rank in Japan
#13,301
of 383,136
Works
147
Citations
1.5k
Citations per work
10.5
h-index
20
i10-index 23Top 23% in Oncology
Kenji Hirotani

What does Kenji Hirotani research?

Kenji Hirotani's work is mostly in Medicine (52%), Chemistry (18%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 76 works · 51.7% of their workMedicine: 76 works · 51.7% of their workOncology: 44 works · 29.8% of their workRadiology, Nuclear Medicine and Imaging: 17 works · 11.3% of their workPulmonary and Respiratory Medicine: 16 works · 10.6% of their workLife Sciences: 30 works · 20.6% of their workBiochemistry, Genetics and Molecular Biology: 24 works · 16.3% of their workMolecular Biology: 24 works · 16.3% of their workImmunology and Microbiology: 6 works · 4.3% of their workImmunology: 6 works · 4.3% of their workPhysical Sciences: 26 works · 17.7% of their workChemistry: 26 works · 17.7% of their workOrganic Chemistry: 26 works · 17.7% of their workEverything else: 15 works · 10.0% of their workTHEIR WORKKenji Hirotani147works
Life Sciences21%Physical Sciences18%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7651.7%
    1. Biochemistry, Genetics and Molecular Biology2416.3%
    2. Immunology and Microbiology64.3%
    1. Chemistry2617.7%
  4. Everything else1510.0%
  1. 1Oncology30% of their works
  2. 2Organic Chemistry18% of their works
  3. 3Molecular Biology16% of their works
  4. 4Radiology, Nuclear Medicine and Imaging11% of their works
  5. 5Pulmonary and Respiratory Medicine11% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Kenji Hirotani's research?

The keywords of their largest research topics: Chemotherapy, Breast Cancer, HER2, Heterocyclic Compounds, Medicinal Chemistry, Fc Receptors, Therapeutic Antibodies and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Chemotherapy242 topics
  2. Breast Cancer191 topic
  3. HER2191 topic
  4. Heterocyclic Compounds152 topics
  5. Medicinal Chemistry152 topics
  6. Fc Receptors121 topic
  7. Therapeutic Antibodies121 topic
  8. EGFR Mutations111 topic
  9. Targeted Therapy111 topic
  10. Catalyst102 topics
  11. Synthesis102 topics
  12. Tubulin Inhibitors101 topic
  13. Vascular Targeting Agents101 topic
  14. Antimicrobial Activity51 topic
  15. DNA51 topic
  16. Imidazoles51 topic
  17. Oxazolones51 topic
  18. Quinoxaline51 topic
  19. Topoisomerases51 topic
  20. VEGF51 topic
  21. endothelial progenitor cells51 topic

Where does Kenji Hirotani work?

Kenji Hirotani's main affiliation in the publication record is Daiichi-Sankyo (Japan), Japan.

How many publications and citations does Kenji Hirotani have?

OpenAlex counts 147 works and 1,542 citations for Kenji Hirotani, an h-index of 20, ranking #993,040 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kenji Hirotani. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.